Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2.

Nurgul Salli, Ugur Salli, Izel Tekin, Jeremy Hengst, Moe K. Zhao, T. Lee Gilman, Anne M. Andrews, Kent Vrana

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Human TPH2 (hTPH2) catalyzes the rate-limiting step in CNS serotonin biosynthesis. We characterized a single-nucleotide polymorphism (C2755A) in the hTPH2 gene that substitutes tyrosine for serine at position 41 in the regulatory domain of the enzyme. This polymorphism is associated with bipolar disorder and peripartum depression in a Chinese population. Recombinant h TPH2 human proteins were expressed in bacteria and also stably expressed in PC12 cells. Following bacterial expression and purification, the tyrosine for serine substitution at position 41 (S41Y) polymorphic enzyme displayed increased Vmax with unchanged Km values. By contrast, enzyme stability was decreased in vitro from 32 min to 4 min (37 °C) for the S41Y enzyme (as compared to the wild-type enzyme). The S41Y polymorphism decreased cyclic AMP-dependent protein kinase A-mediated phosphorylation ~ 50% relative to wild-type hTPH2, suggesting that the S41Y mutation may disrupt the post-translational regulation of this enzyme. Transfected PC12 cells expressed hTPH2 mRNA, active protein, and synthesized and released serotonin. Paradoxically, while S41Y-transfected PC12 cells expressed higher levels of hTPH2 than wild type, they synthesized less serotonin. These findings suggest a modified regulation of the S41Y gene variant leading to altered regulation and reduced neurotransmitter synthesis that may contribute to association of the polymorphism with bipolar disorder and depression. We report the functional implications of a polymorphic human tryptophan hydroxylase-2 gene associated with depression and bipolar disorder. The polymorphic enzyme (serine-41 converted to tyrosine) has increased activity, but decreased enzyme stability and serotonin production. Moreover, cyclic AMP-dependent protein kinase (PKA)-mediated phosphorylation of the mutant enzyme is decreased suggesting modified regulation of the S41Y variant leading to altered serotonin.

Original languageEnglish (US)
Pages (from-to)748-758
Number of pages11
JournalJournal of neurochemistry
Volume130
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Tryptophan Hydroxylase
Polymorphism
Serotonin
Bipolar Disorder
Enzymes
PC12 Cells
Cyclic AMP-Dependent Protein Kinases
Serine
Tyrosine
Enzyme Stability
Phosphorylation
Genes
Depression
Peripartum Period
Single Nucleotide Polymorphism
Neurotransmitter Agents
Biosynthesis
Purification
Bacteria
Substitution reactions

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Salli, Nurgul ; Salli, Ugur ; Tekin, Izel ; Hengst, Jeremy ; Zhao, Moe K. ; Gilman, T. Lee ; Andrews, Anne M. ; Vrana, Kent. / Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2. In: Journal of neurochemistry. 2014 ; Vol. 130, No. 6. pp. 748-758.
@article{e99a5b2f48464b2f978108f0ff47b501,
title = "Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2.",
abstract = "Human TPH2 (hTPH2) catalyzes the rate-limiting step in CNS serotonin biosynthesis. We characterized a single-nucleotide polymorphism (C2755A) in the hTPH2 gene that substitutes tyrosine for serine at position 41 in the regulatory domain of the enzyme. This polymorphism is associated with bipolar disorder and peripartum depression in a Chinese population. Recombinant h TPH2 human proteins were expressed in bacteria and also stably expressed in PC12 cells. Following bacterial expression and purification, the tyrosine for serine substitution at position 41 (S41Y) polymorphic enzyme displayed increased Vmax with unchanged Km values. By contrast, enzyme stability was decreased in vitro from 32 min to 4 min (37 °C) for the S41Y enzyme (as compared to the wild-type enzyme). The S41Y polymorphism decreased cyclic AMP-dependent protein kinase A-mediated phosphorylation ~ 50{\%} relative to wild-type hTPH2, suggesting that the S41Y mutation may disrupt the post-translational regulation of this enzyme. Transfected PC12 cells expressed hTPH2 mRNA, active protein, and synthesized and released serotonin. Paradoxically, while S41Y-transfected PC12 cells expressed higher levels of hTPH2 than wild type, they synthesized less serotonin. These findings suggest a modified regulation of the S41Y gene variant leading to altered regulation and reduced neurotransmitter synthesis that may contribute to association of the polymorphism with bipolar disorder and depression. We report the functional implications of a polymorphic human tryptophan hydroxylase-2 gene associated with depression and bipolar disorder. The polymorphic enzyme (serine-41 converted to tyrosine) has increased activity, but decreased enzyme stability and serotonin production. Moreover, cyclic AMP-dependent protein kinase (PKA)-mediated phosphorylation of the mutant enzyme is decreased suggesting modified regulation of the S41Y variant leading to altered serotonin.",
author = "Nurgul Salli and Ugur Salli and Izel Tekin and Jeremy Hengst and Zhao, {Moe K.} and Gilman, {T. Lee} and Andrews, {Anne M.} and Kent Vrana",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/jnc.12779",
language = "English (US)",
volume = "130",
pages = "748--758",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2. / Salli, Nurgul; Salli, Ugur; Tekin, Izel; Hengst, Jeremy; Zhao, Moe K.; Gilman, T. Lee; Andrews, Anne M.; Vrana, Kent.

In: Journal of neurochemistry, Vol. 130, No. 6, 01.01.2014, p. 748-758.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2.

AU - Salli, Nurgul

AU - Salli, Ugur

AU - Tekin, Izel

AU - Hengst, Jeremy

AU - Zhao, Moe K.

AU - Gilman, T. Lee

AU - Andrews, Anne M.

AU - Vrana, Kent

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Human TPH2 (hTPH2) catalyzes the rate-limiting step in CNS serotonin biosynthesis. We characterized a single-nucleotide polymorphism (C2755A) in the hTPH2 gene that substitutes tyrosine for serine at position 41 in the regulatory domain of the enzyme. This polymorphism is associated with bipolar disorder and peripartum depression in a Chinese population. Recombinant h TPH2 human proteins were expressed in bacteria and also stably expressed in PC12 cells. Following bacterial expression and purification, the tyrosine for serine substitution at position 41 (S41Y) polymorphic enzyme displayed increased Vmax with unchanged Km values. By contrast, enzyme stability was decreased in vitro from 32 min to 4 min (37 °C) for the S41Y enzyme (as compared to the wild-type enzyme). The S41Y polymorphism decreased cyclic AMP-dependent protein kinase A-mediated phosphorylation ~ 50% relative to wild-type hTPH2, suggesting that the S41Y mutation may disrupt the post-translational regulation of this enzyme. Transfected PC12 cells expressed hTPH2 mRNA, active protein, and synthesized and released serotonin. Paradoxically, while S41Y-transfected PC12 cells expressed higher levels of hTPH2 than wild type, they synthesized less serotonin. These findings suggest a modified regulation of the S41Y gene variant leading to altered regulation and reduced neurotransmitter synthesis that may contribute to association of the polymorphism with bipolar disorder and depression. We report the functional implications of a polymorphic human tryptophan hydroxylase-2 gene associated with depression and bipolar disorder. The polymorphic enzyme (serine-41 converted to tyrosine) has increased activity, but decreased enzyme stability and serotonin production. Moreover, cyclic AMP-dependent protein kinase (PKA)-mediated phosphorylation of the mutant enzyme is decreased suggesting modified regulation of the S41Y variant leading to altered serotonin.

AB - Human TPH2 (hTPH2) catalyzes the rate-limiting step in CNS serotonin biosynthesis. We characterized a single-nucleotide polymorphism (C2755A) in the hTPH2 gene that substitutes tyrosine for serine at position 41 in the regulatory domain of the enzyme. This polymorphism is associated with bipolar disorder and peripartum depression in a Chinese population. Recombinant h TPH2 human proteins were expressed in bacteria and also stably expressed in PC12 cells. Following bacterial expression and purification, the tyrosine for serine substitution at position 41 (S41Y) polymorphic enzyme displayed increased Vmax with unchanged Km values. By contrast, enzyme stability was decreased in vitro from 32 min to 4 min (37 °C) for the S41Y enzyme (as compared to the wild-type enzyme). The S41Y polymorphism decreased cyclic AMP-dependent protein kinase A-mediated phosphorylation ~ 50% relative to wild-type hTPH2, suggesting that the S41Y mutation may disrupt the post-translational regulation of this enzyme. Transfected PC12 cells expressed hTPH2 mRNA, active protein, and synthesized and released serotonin. Paradoxically, while S41Y-transfected PC12 cells expressed higher levels of hTPH2 than wild type, they synthesized less serotonin. These findings suggest a modified regulation of the S41Y gene variant leading to altered regulation and reduced neurotransmitter synthesis that may contribute to association of the polymorphism with bipolar disorder and depression. We report the functional implications of a polymorphic human tryptophan hydroxylase-2 gene associated with depression and bipolar disorder. The polymorphic enzyme (serine-41 converted to tyrosine) has increased activity, but decreased enzyme stability and serotonin production. Moreover, cyclic AMP-dependent protein kinase (PKA)-mediated phosphorylation of the mutant enzyme is decreased suggesting modified regulation of the S41Y variant leading to altered serotonin.

UR - http://www.scopus.com/inward/record.url?scp=84908241146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908241146&partnerID=8YFLogxK

U2 - 10.1111/jnc.12779

DO - 10.1111/jnc.12779

M3 - Article

C2 - 24899127

AN - SCOPUS:84908241146

VL - 130

SP - 748

EP - 758

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -